Study Stopped
Inadequate recruiting
Endocrine Outcome of Surgery for Pituitary Adenoma
Compare Between Endoscopic and Microsurgical Transsphenoidal Resection of Pituitary Adenomas With Intraoperative MRI
1 other identifier
interventional
36
1 country
1
Brief Summary
Prospective and randomized compare between microsurgical and endoscopic transsphenoidal MRI assisted resection of pituitary adenomas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2018
CompletedFirst Posted
Study publicly available on registry
May 3, 2018
CompletedStudy Start
First participant enrolled
May 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 17, 2023
May 1, 2023
4.6 years
April 14, 2018
May 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
endocrine function
Testing of pituitary function with insulin-hypoglycemic test, results will be dichotomized as satisfactory or not satisfactory. Satisfactory outcome is defined, if pituitary function improves or is stable, if compared to preoperative testing.
1 year after surgery
Secondary Outcomes (2)
Extent of resection
tumor volume before the surgery, 3 months after surgery
Quality of Life, EQ-5D
3 months and 1 year after surgery
Study Arms (2)
microsurgical technique
ACTIVE COMPARATORendoscopic technique
ACTIVE COMPARATORInterventions
Transsphenoidal endoscopic resection of pituitary adenoma
Transsphenoidal microsurgical resection of pituitary adenoma
Eligibility Criteria
You may qualify if:
- Suspected symptomatic or progressively growing pituitary adenoma
- Informed consent
You may not qualify if:
- Prolactinoma
- No follow-up possible
- Emergency surgery without informed consent or without intraoperative MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurosurgery
Günzburg, 89312, Germany
Related Publications (1)
Pala A, Grubel N, Mayer B, Becker R, Sommer F, Schmitz B, Etzrodt-Walter G, Wirtz CR, Hlavac M. Endocrine Outcome and Quality of Life After Transsphenoidal Resection of Pituitary Adenoma-A Prospective Randomized Single-Blinded Study Comparing Endoscopic Versus Microscopic Resection. Neurol Int. 2025 Jan 10;17(1):5. doi: 10.3390/neurolint17010005.
PMID: 39852769DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrej Pala, MD
University Ulm, Department of Neurosurgery
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- only surgeon knows the used technique, endocrinologist, patient and all involved medical staff is blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 14, 2018
First Posted
May 3, 2018
Study Start
May 10, 2018
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
May 17, 2023
Record last verified: 2023-05